Premium
Maternal factors in the origin of infantile hypertrophic pyloric stenosis: A population‐based case‐control study
Author(s) -
Vermes Gabor,
László Daniel,
Czeizel† Andrew E.,
Ács Nándor
Publication year - 2016
Publication title -
congenital anomalies
Language(s) - English
Resource type - Journals
eISSN - 1741-4520
pISSN - 0914-3505
DOI - 10.1111/cga.12134
Subject(s) - hypertrophic pyloric stenosis , medicine , etiology , population , pediatrics , pyloric stenosis , nalidixic acid , pregnancy , case control study , obstetrics , antibiotics , environmental health , genetics , antibiotic resistance , microbiology and biotechnology , biology
In most patients affected by isolated infantile hypertrophic pyloric stenosis ( IHPS ) the etiology is largely unknown. Thus, the aim of this study was to estimate possible maternal risk factors in the origin of IHPS . The study samples included 241 cases with IHPS , 357 matched controls and 38 151 population controls without any defect in the population‐based large dataset of the H ungarian C ase‐ C ontrol S urveillance of C ongenital A bnormalities, 1980–1996. Exposures that had been medically recorded in prenatal maternity logbooks during the critical period of IHPS were evaluated separately. The findings of this case‐control study suggested that – beyond the well‐known robust male excess (85.5%) – maternal hyperthyroidism ( OR with 95% CI : 4.17, 1.53–11.38) and oral nalidixic acid treatment ( OR with 95% CI : 6.53, 3.03–14.06) associated with a higher risk for IHPS in their children. In conclusion, our findings suggest that cases with IHPS had mothers with a higher proportion of hyperthyroidism and nalidixic acid treatment during pregnancy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom